LUND, V. J., CLARKE, P. M., SWIFT, A. C., MCGARRY, G. W., KERAWALA, C., and CARNELL, D.
Subjects
CANCER patients, CANCER patient medical care, HEAD tumors, MEDICAL protocols, NECK tumors, NASAL tumors, PARANASAL sinus cancer, DISEASE management, DISEASE incidence
Abstract
This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. With only limited high-level evidence for management of nasal and paranasal sinus cancers owing to low incidence and diverse histology, this paper provides recommendations on the work up and management based on the existing evidence base. [ABSTRACT FROM AUTHOR]
PRACY, P., LOUGHRAN, S., GOOD, J., PARMAR, S., and GORANOVA, R.
Subjects
AGE distribution, CANCER patients, CANCER patient medical care, HEAD tumors, MEDICAL protocols, NECK tumors, DISEASE management, HYPOPHARYNX, DISEASE incidence, TUMORS
Abstract
This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. With an age standardised incidence rate of 0.63 per 100 000 population, hypopharynx cancers account for a small proportion of the head and neck cancer workload in the UK, and thus suffer from the lack of high level evidence. This paper discusses the evidence base pertaining to the management of hypopharyngeal cancer and provides recommendations on management for this group of patients receiving cancer care. [ABSTRACT FROM AUTHOR]
SIMO, R., ROBINSON, M., LEI, M., SIBTAIN, A., and HICKEY, S.
Subjects
AGE distribution, CANCER patients, CANCER patient medical care, HEAD tumors, MEDICAL protocols, NASOPHARYNX tumors, NECK tumors, DISEASE management, DISEASE incidence
Abstract
This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. Although much commoner in the eastern hemisphere, with an age-standardised incidence rate of 0.39 per 100 000 population, cancers of the nasopharynx form one of the rarer subsites in the head and neck.¹ This paper provides recommendations on the work up and management of nasopharyngeal cancer based on the existing evidence base for this condition. [ABSTRACT FROM AUTHOR]
MEHANNA, H., EVANS, M., BEASLEY, M., CHATTERJEE, S., DILKES, M., HOMER, J., O'HARA, J., ROBINSON, M., SHAW, R., and SLOAN, P.
Subjects
CANCER patients, CANCER patient medical care, HEAD tumors, MEDICAL protocols, NECK tumors, PAPILLOMAVIRUSES, DISEASE incidence, OROPHARYNGEAL cancer, CANCER treatment
Abstract
This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. There has been significant debate in the management of oropharyngeal cancer in the last decade, especially in light of the increased incidence, clarity on the role of the human papilloma virus in this disease and the treatment responsiveness of the human papilloma virus positive cancers. This paper discusses the evidence base pertaining to the management of oropharyngeal cancer and provides recommendations on management for this group of patients receiving cancer care. [ABSTRACT FROM AUTHOR]